Acute Myeloid Leukemia (AML) is a highly proliferating blood cell disorder that starts in the bone marrow and affects the normal production of blood cells. According to global cancer statistics, every year there are hundreds of thousands of new cases of leukemia, and AML is known to be the most aggressive form in adults. Precision medicine has introduced many targeted therapies that address specific mutations causing the growth of cancer cells. Enasidenib 50 mg Tablet is an innovative drug used to treat AML with mutations in the IDH2 gene. It is a targeted therapy that specifically treats the underlying cause of the disease.
What is the Enasidenib Tablet mechanism of action ?
It is an oral targeted therapy drug that selectively inhibits the activity of mutant Isocitrate Dehydrogenase 2 (IDH2) enzyme. Enasidenib selectively inhibits mutant IDH2 enzyme activity, which in turn reduces 2-HG production. This allows abnormal leukemic cells to differentiate into healthy cells again. Result in controlling the progression of disease.
What are the Uses of Enasidenib?
Doctor primarily prescribed it for the treatment of:
- Relapsed or refractory Acute Myeloid Leukemia (AML) with an IDH2 mutation
- Patients whose leukemia has come back after initial treatment
- Patients who are not responding to chemotherapy
Dosage and Administration
The dosage of this medicine should always be determined by a healthcare professional.
It is usually taken once a day with water and tablet should be taken whole. It can be taken with or without food but at the same time each day for it to work properly.
Possible Side Effects
Like any other anticancer medications, it also may cause certain adverse effects. However, not all patients experience them.
Common Enasidenib 50 mg Tablet side effects include:
- Nausea
- Vomiting
- Diarrhea
- Loss of appetite
- Fatigue
- Weakness
- Elevated bilirubin levels
- Shortness of breath
Precautions and Warnings
- Blood tests need to be regularly taken to check how the treatment is responding.
- Liver function should be checked during treatment
- Pregnant and breastfeeding women
- Fever, difficulty in breathing, and swelling should be reported to the doctor immediately
Conclusion
This tablet is a significant breakthrough in the treatment of IDH2 mutated cases of Acute Myeloid Leukemia. It works by specifically targeting the mutated gene responsible for the progression of leukemia. It provides a more targeted therapy than conventional chemotherapy. Although the drug may lead to some side effects, it can be effectively managed under proper medical supervision. It has brought new hope to patients of relapsed or refractory AML, providing better therapeutic outcomes for those eligible to take the drug.
FAQs
Q-How long does it take for this medicine to work?
A-The time taken for it to work may vary; however, it has to be monitored for weeks to months.
Q-Can Enasidenib be taken with food?A-Yes, it may be taken with or without meals unless specifically advised by a doctor.
